FNY Investment Advisers’s CERo Therapeutics CERO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Buy |
1,050
+1,037
| +7,977% | +$9.88K | ﹤0.01% | 650 |
|
|
2025
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 992 |
|
|
2024
Q4 | $157K | Hold |
13
| – | – | 0.08% | 219 |
|
|
2024
Q3 | $2K | Buy |
13
+10
| +333% | +$1.54K | ﹤0.01% | 576 |
|
|
2024
Q2 | $1K | Sell |
3
-2
| -40% | -$667 | ﹤0.01% | 386 |
|
|
2024
Q1 | $32 | Buy |
+5
| New | +$32 | 0.02% | 311 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | -$22K | – | 758 |
|
|
2023
Q2 | $22K | Buy |
+1
| New | +$22K | 0.03% | 230 |
|